The C17 measure carries a 2026 national numeric average of 77%, while the five-star threshold requires a rate of 87%, and that ten-point gap is likely attributable to documentation and timing failures, rather than gaps in clinical care. Reconciliation that is not recorded, or recorded after the 31-day window does not earn credit. Medication reconciliation itself improves outcomes: in a meta-analysis, pharmacist-led medication reconciliation programs reduced all-cause readmissions by about 19% and emergency department visits by about 28%.
AAVBC's Medication Reconciliation Post Discharge Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering the measure specification and 31-day window, CPT-II 1111F and eligible bundled coding, qualifying professionals and non-face-to-face pathways, discharge notification and workflow ownership, structured reconciliation call design, common pitfalls and practical fixes, barriers affecting patients with limited English proficiency, and the measure's retirement into Transitions of Care beginning Star Year 2027. Grounded in current CMS and HEDIS specifications, this guide supports consistent, individualized clinical decision-making, helping care teams reconcile and document post-discharge medications reliably, with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of C17 performance — moving far beyond quick-reference essentials. These guides provide an integrated review of measurement importance and impact, clinical integrations, technical details, challenges and barriers, strategies for team coordination and quality improvement as well as regulatory and financial considerations. The Deep-Dives combine evidence-informed clinical guidance with practical operational tools to support a deeper understanding of C17 performance and provide care teams with strategies to thrive within a value-based model.
The C17 measure carries a 2026 national numeric average of 77%, while the five-star threshold requires a rate of 87%, and that ten-point gap is likely attributable to documentation and timing failures, rather than gaps in clinical care. Reconciliation that is not recorded, or recorded after the 31-day window does not earn credit. Medication reconciliation itself improves outcomes: in a meta-analysis, pharmacist-led medication reconciliation programs reduced all-cause readmissions by about 19% and emergency department visits by about 28%.
AAVBC's Medication Reconciliation Post Discharge Quick Reference Guide equips primary care clinicians and care teams with a comprehensive, evidence-aligned reference covering the measure specification and 31-day window, CPT-II 1111F and eligible bundled coding, qualifying professionals and non-face-to-face pathways, discharge notification and workflow ownership, structured reconciliation call design, common pitfalls and practical fixes, barriers affecting patients with limited English proficiency, and the measure's retirement into Transitions of Care beginning Star Year 2027. Grounded in current CMS and HEDIS specifications, this guide supports consistent, individualized clinical decision-making, helping care teams reconcile and document post-discharge medications reliably, with the clarity and continuity that durable outcomes require.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of C17 performance — moving far beyond quick-reference essentials. These guides provide an integrated review of measurement importance and impact, clinical integrations, technical details, challenges and barriers, strategies for team coordination and quality improvement as well as regulatory and financial considerations. The Deep-Dives combine evidence-informed clinical guidance with practical operational tools to support a deeper understanding of C17 performance and provide care teams with strategies to thrive within a value-based model.
